Charlotte Dyring
​
Charlotte has a scientific background with a master in chemical engineering and a Nordic Industrial PhD in Biotechnology at Pharmacia & Upjohn, Stockholm. Professionally, Charlotte has more than 30 years industry experience from pharma and biotech where she has held diverse roles, from scientist to various managerial positions in biotech and pharma companies. ​
 

As a co-founder and former CEO of ExpreS2ion Biotechnologies, Charlotte secured investments, led the company to become a global CRO, and orchestrated a successful IPO on Nasdaq First North, Stockholm in 2016. Her efforts also fostered partnerships with prestigious institutions, contributing to impactful projects, such as malaria vaccines in human clinical trials.​
 

Charlotte has solid experience in growing start-ups and securing partnerships and funding. She has successfully executed several national and international grants. ​
 

Charlotte establishes the necessary organizational structure in Marigold's companies to ensure operational excellence.​